Hemophilia News Today Forums Forums Hemophilia Treatment A new class of hemophilia drugs.

  • A new class of hemophilia drugs.

    Posted by milos on September 1, 2022 at 9:36 am

    Is the mentioned drug registered anywhere in the world?

     

    milos replied 1 year ago 2 Members · 5 Replies
  • 5 Replies
  • cazandra-campos-macdonald

    Moderator
    September 2, 2022 at 4:34 pm

    Hi Milos, May I ask which drug you are referring to? Are you talking about the recent news regarding gene therapy?

  • milos

    Member
    September 3, 2022 at 12:35 am

    Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma.

  • cazandra-campos-macdonald

    Moderator
    September 4, 2022 at 3:28 pm

    Milos, Iā€™m doing some research and will get back to you soon šŸ™‚

  • cazandra-campos-macdonald

    Moderator
    September 13, 2022 at 11:27 am

    Hi Milos,
    I have reached out to a few clinicians about your question, and they have no information to share. I will keep my ears open and ask that you do the same.

    Thank you!! Have a great week, Milos šŸ™‚

  • milos

    Member
    October 1, 2022 at 11:06 am

    Thank you, Cazandra.

  • paulc

    Member
    October 7, 2022 at 9:53 am

    Milos, there is no anti-activated protein C (anti-APC) drug on the on the market in any country. ApcinteX Ltd and Centessa Pharmaceuticals are testing (phase 1/2 clinical trial) an anti-APC drug called SerpinPC (clinical trial # NCT04073498), with results expected in October 2023. See press release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-positive-topline-data-proof

Log in to reply.